跳至主要内容
临床试验/CTRI/2024/06/068558
CTRI/2024/06/068558尚未招募Unknown

A randomized double-blind placebo controlled trial to compare the safety and efficacy of probiotic formulation in Indian patients with Atopic Dermatitis - NI

nique Biotech Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients with age of two to eighteen years diagnosed with atopic dermatitis (mild to moderate (SCORAD of 50).

排除标准

  • 1)Patient with associated (inflammatory and infectious) skin diseases
  • 2)Patients using oral corticosteroids or monoclonal antibodies or immunosuppressants within 30 days before enrolment.
  • 3)Use of phototherapy for AD in the previous 2 months.
  • 4)Probiotic intake in the previous 2 months.
  • 5)Systemic antibiotic treatment in the previous 4 days; fever
  • 6)Patients in whom any of the study products is contraindicated.
  • 7)Patients who have participated in research studies with medicinal products during the previous 3 months.
  • 8)patients with gluten or lactose intolerance or inflammatory bowel disease (Crohn disease or ulcerative colitis)

研究者

发起方
nique Biotech Ltd.

相似试验